<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35163623</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>30</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>23</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Feb</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Inhibition of the Akt/PKB Kinase Increases Na<sub>v</sub>1.6-Mediated Currents and Neuronal Excitability in CA1 Hippocampal Pyramidal Neurons.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">1700</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23031700</ELocationID>
        <Abstract>
          <AbstractText>In neurons, changes in Akt activity have been detected in response to the stimulation of transmembrane receptors. However, the mechanisms that lead to changes in neuronal function upon Akt inhibition are still poorly understood. In the present study, we interrogate how Akt inhibition could affect the activity of the neuronal Na<sub>v</sub> channels with while impacting intrinsic excitability. To that end, we employed voltage-clamp electrophysiological recordings in heterologous cells expressing the Na<sub>v</sub>1.6 channel isoform and in hippocampal CA1 pyramidal neurons in the presence of triciribine, an inhibitor of Akt. We showed that in both systems, Akt inhibition resulted in a potentiation of peak transient Na+ current (<i>I</i><sub>Na</sub>) density. Akt inhibition correspondingly led to an increase in the action potential firing of the CA1 pyramidal neurons that was accompanied by a decrease in the action potential current threshold. Complementary confocal analysis in the CA1 pyramidal neurons showed that the inhibition of Akt is associated with the lengthening of Na<sub>v</sub>1.6 fluorescent intensity along the axonal initial segment (AIS), providing a mechanism for augmented neuronal excitability. Taken together, these findings provide evidence that Akt-mediated signal transduction might affect neuronal excitability in a Na<sub>v</sub>1.6-dependent manner.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Marosi</LastName>
            <ForeName>Mate</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology &amp; Toxicology, The University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nenov</LastName>
            <ForeName>Miroslav N</ForeName>
            <Initials>MN</Initials>
            <Identifier Source="ORCID">0000-0001-6000-2372</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology &amp; Toxicology, The University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Di Re</LastName>
            <ForeName>Jessica</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-3819-1362</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology &amp; Toxicology, The University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dvorak</LastName>
            <ForeName>Nolan M</ForeName>
            <Initials>NM</Initials>
            <Identifier Source="ORCID">0000-0003-1280-9918</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology &amp; Toxicology, The University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alshammari</LastName>
            <ForeName>Musaad</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-5165-1095</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology &amp; Toxicology, The University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology, College of Pharmacy, King Saud University, Riyadh P.O. Box 145111, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laezza</LastName>
            <ForeName>Fernanda</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">0000-0003-1141-1852</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology &amp; Toxicology, The University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Addiction Research, Center for Biomedical Engineering and Mitchell, Center for Neurodegenerative Diseases, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>GM008280</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>NIH/NIEHS-T32ES007254</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01ES031823</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 MH124351</GrantID>
            <Acronym>MH</Acronym>
            <Agency>NIMH NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 ES031823</GrantID>
            <Acronym>ES</Acronym>
            <Agency>NIEHS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>NIH/NIMH R01MH124351</GrantID>
            <Acronym>NH</Acronym>
            <Agency>NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D062557">NAV1.6 Voltage-Gated Sodium Channel</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000200" MajorTopicYN="Y">Action Potentials</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062557" MajorTopicYN="N">NAV1.6 Voltage-Gated Sodium Channel</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
          <QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017966" MajorTopicYN="N">Pyramidal Cells</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">axon initial segment</Keyword>
        <Keyword MajorTopicYN="N">electrophysiology</Keyword>
        <Keyword MajorTopicYN="N">immunohistochemistry</Keyword>
        <Keyword MajorTopicYN="N">neuronal excitability</Keyword>
        <Keyword MajorTopicYN="N">protein kinase B (PKB)/Akt</Keyword>
        <Keyword MajorTopicYN="N">voltage-gated sodium channels</Keyword>
      </KeywordList>
      <CoiStatement>The corresponding author, F.L., is the founder and president of IonTx Inc. (Galveston, TX, USA), a start-up company focusing on developing regulators of voltage-gated Na<sup>+</sup> channels. However, this activity does not represent a conflict with the present study.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>15</Day>
          <Hour>1</Hour>
          <Minute>18</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35163623</ArticleId>
        <ArticleId IdType="pmc">PMC8836202</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms23031700</ArticleId>
        <ArticleId IdType="pii">ijms23031700</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Brazil D.P., Yang Z.-Z., Hemmings B.A. Advances in Protein Kinase B Signalling: AKTion on Multiple Fronts. Trends Biochem. Sci. 2004;29:233–242. doi: 10.1016/j.tibs.2004.03.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tibs.2004.03.006</ArticleId>
            <ArticleId IdType="pubmed">15130559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brunet A., Datta S.R., Greenberg M.E. Transcription-Dependent and -Independent Control of Neuronal Survival by the PI3K–Akt Signaling Pathway. Curr. Opin. Neurobiol. 2001;11:297–305. doi: 10.1016/S0959-4388(00)00211-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0959-4388(00)00211-7</ArticleId>
            <ArticleId IdType="pubmed">11399427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho H., Thorvaldsen J.L., Chu Q., Feng F., Birnbaum M.J. Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice. J. Biol. Chem. 2001;276:38349–38352. doi: 10.1074/jbc.C100462200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.C100462200</ArticleId>
            <ArticleId IdType="pubmed">11533044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Datta S.R., Brunet A., Greenberg M.E. Cellular Survival: A Play in Three Akts. Genes Dev. 1999;13:2905–2927. doi: 10.1101/gad.13.22.2905.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.13.22.2905</ArticleId>
            <ArticleId IdType="pubmed">10579998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dummler B., Tschopp O., Hynx D., Yang Z.-Z., Dirnhofer S., Hemmings B.A. Life with a Single Isoform of Akt: Mice Lacking Akt2 and Akt3 Are Viable but Display Impaired Glucose Homeostasis and Growth Deficiencies. Mol. Cell. Biol. 2006;26:8042–8051. doi: 10.1128/MCB.00722-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.00722-06</ArticleId>
            <ArticleId IdType="pmc">PMC1636753</ArticleId>
            <ArticleId IdType="pubmed">16923958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manning B.D., Cantley L.C. AKT/PKB Signaling: Navigating Downstream. Cell. 2007;129:1261–1274. doi: 10.1016/j.cell.2007.06.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2007.06.009</ArticleId>
            <ArticleId IdType="pmc">PMC2756685</ArticleId>
            <ArticleId IdType="pubmed">17604717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manning B.D., Toker A. AKT/PKB Signaling: Navigating the Network. Cell. 2017;169:381–405. doi: 10.1016/j.cell.2017.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2017.04.001</ArticleId>
            <ArticleId IdType="pmc">PMC5546324</ArticleId>
            <ArticleId IdType="pubmed">28431241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tschopp O., Yang Z.-Z., Brodbeck D., Dummler B.A., Hemmings-Mieszczak M., Watanabe T., Michaelis T., Frahm J., Hemmings B.A. Essential Role of Protein Kinase Bγ (PKBγ/Akt3) in Postnatal Brain Development but Not in Glucose Homeostasis. Development. 2005;132:2943–2954. doi: 10.1242/dev.01864.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dev.01864</ArticleId>
            <ArticleId IdType="pubmed">15930105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vivanco I., Sawyers C.L. The Phosphatidylinositol 3-Kinase–AKT Pathway in Human Cancer. Nat. Rev. Cancer. 2002;2:489–501. doi: 10.1038/nrc839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc839</ArticleId>
            <ArticleId IdType="pubmed">12094235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar C.C., Madison V. AKT Crystal Structure and AKT-Specific Inhibitors. Oncogene. 2005;24:7493–7501. doi: 10.1038/sj.onc.1209087.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1209087</ArticleId>
            <ArticleId IdType="pubmed">16288296</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manning B.D., Tee A.R., Logsdon M.N., Blenis J., Cantley L.C. Identification of the Tuberous Sclerosis Complex-2 Tumor Suppressor Gene Product Tuberin as a Target of the Phosphoinositide 3-Kinase/Akt Pathway. Mol. Cell. 2002;10:151–162. doi: 10.1016/S1097-2765(02)00568-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1097-2765(02)00568-3</ArticleId>
            <ArticleId IdType="pubmed">12150915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellacosa A., Chan T.O., Ahmed N.N., Datta K., Malstrom S., Stokoe D., McCormick F., Feng J., Tsichlis P. Akt Activation by Growth Factors Is a Multiple-Step Process: The Role of the PH Domain. Oncogene. 1998;17:313–325. doi: 10.1038/sj.onc.1201947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1201947</ArticleId>
            <ArticleId IdType="pubmed">9690513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burgering B.M.T., Coffer P.J. Protein Kinase B (c-Akt) in Phosphatidylinositol-3-OH Kinase Signal Transduction. Nature. 1995;376:599–602. doi: 10.1038/376599a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/376599a0</ArticleId>
            <ArticleId IdType="pubmed">7637810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Datta K., Franke T.F., Chan T.O., Makris A., Yang S.I., Kaplan D.R., Morrison D.K., Golemis E.A., Tsichlis P.N. AH/PH Domain-Mediated Interaction between Akt Molecules and Its Potential Role in Akt Regulation. Mol. Cell. Biol. 1995;15:2304–2310. doi: 10.1128/MCB.15.4.2304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.15.4.2304</ArticleId>
            <ArticleId IdType="pmc">PMC230458</ArticleId>
            <ArticleId IdType="pubmed">7891724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebner M., Lučić I., Leonard T.A., Yudushkin I. PI(3,4,5)P 3 Engagement Restricts Akt Activity to Cellular Membranes. Mol. Cell. 2017;65:416–431. doi: 10.1016/j.molcel.2016.12.028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2016.12.028</ArticleId>
            <ArticleId IdType="pubmed">28157504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franke T.F., Kaplan D.R., Cantley L.C. PI3K: Downstream AKTion Blocks Apoptosis. Cell. 1997;88:435–437. doi: 10.1016/S0092-8674(00)81883-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(00)81883-8</ArticleId>
            <ArticleId IdType="pubmed">9038334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stokoe D., Stephens L.R., Copeland T., Gaffney P.R.J., Reese C.B., Painter G.F., Holmes A.B., McCormick F., Hawkins P.T. Dual Role of Phosphatidylinositol-3,4,5-Trisphosphate in the Activation of Protein Kinase B. Science. 1997;277:567–570. doi: 10.1126/science.277.5325.567.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.277.5325.567</ArticleId>
            <ArticleId IdType="pubmed">9228007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas C.C., Deak M., Alessi D.R., van Aalten D.M.F. High-Resolution Structure of the Pleckstrin Homology Domain of Protein Kinase B/Akt Bound to Phosphatidylinositol (3,4,5)-Trisphosphate. Curr. Biol. 2002;12:1256–1262. doi: 10.1016/S0960-9822(02)00972-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0960-9822(02)00972-7</ArticleId>
            <ArticleId IdType="pubmed">12176338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of Activation of Protein Kinase B by Insulin and IGF-1. EMBO J. 1996;15:6541–6551. doi: 10.1002/j.1460-2075.1996.tb01045.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/j.1460-2075.1996.tb01045.x</ArticleId>
            <ArticleId IdType="pmc">PMC452479</ArticleId>
            <ArticleId IdType="pubmed">8978681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alessi D.R., Deak M., Casamayor A., Barry Caudwell F., Morrice N., Norman D.G., Gaffney P., Reese C.B., MacDougall C.N., Harbison D., et al.  3-Phosphoinositide-Dependent Protein Kinase-1 (PDK1): Structural and Functional Homology with the Drosophila DSTPK61 Kinase. Curr. Biol. 1997;7:776–789. doi: 10.1016/S0960-9822(06)00336-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0960-9822(06)00336-8</ArticleId>
            <ArticleId IdType="pubmed">9368760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meier R., Alessi D.R., Cron P., Andjelković M., Hemmings B.A. Mitogenic Activation, Phosphorylation, and Nuclear Translocation of Protein Kinase Bβ. J. Biol. Chem. 1997;272:30491–30497. doi: 10.1074/jbc.272.48.30491.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.272.48.30491</ArticleId>
            <ArticleId IdType="pubmed">9374542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stephens L., Anderson K., Stokoe D., Erdjument-Bromage H., Painter G.F., Holmes A.B., Gaffney P.R.J., Reese C.B., McCormick F., Tempst P., et al.  Protein Kinase B Kinases That Mediate Phosphatidylinositol 3,4,5-Trisphosphate-Dependent Activation of Protein Kinase B. Science. 1998;279:710–714. doi: 10.1126/science.279.5351.710.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.279.5351.710</ArticleId>
            <ArticleId IdType="pubmed">9445477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanada M., Feng J., Hemmings B.A. Structure, Regulation and Function of PKB/AKT—A Major Therapeutic Target. Biochim. Biophys. Acta Proteins Proteom. 2004;1697:3–16. doi: 10.1016/j.bbapap.2003.11.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbapap.2003.11.009</ArticleId>
            <ArticleId IdType="pubmed">15023346</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obata T., Yaffe M.B., Leparc G.G., Piro E.T., Maegawa H., Kashiwagi A., Kikkawa R., Cantley L.C. Peptide and Protein Library Screening Defines Optimal Substrate Motifs for AKT/PKB. J. Biol. Chem. 2000;275:36108–36115. doi: 10.1074/jbc.M005497200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M005497200</ArticleId>
            <ArticleId IdType="pubmed">10945990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of Glycogen Synthase Kinase-3 by Insulin Mediated by Protein Kinase B. Nature. 1995;378:785–789. doi: 10.1038/378785a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/378785a0</ArticleId>
            <ArticleId IdType="pubmed">8524413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Linding R., Jensen L.J., Ostheimer G.J., van Vugt M.A.T.M., Jørgensen C., Miron I.M., Diella F., Colwill K., Taylor L., Elder K., et al.  Systematic Discovery of In Vivo Phosphorylation Networks. Cell. 2007;129:1415–1426. doi: 10.1016/j.cell.2007.05.052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2007.05.052</ArticleId>
            <ArticleId IdType="pmc">PMC2692296</ArticleId>
            <ArticleId IdType="pubmed">17570479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sutherland C., Leighton I.A., Cohen P. Inactivation of Glycogen Synthase Kinase-3 Beta by Phosphorylation: New Kinase Connections in Insulin and Growth-Factor Signalling. Biochem. J. 1993;296:15–19. doi: 10.1042/bj2960015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/bj2960015</ArticleId>
            <ArticleId IdType="pmc">PMC1137648</ArticleId>
            <ArticleId IdType="pubmed">8250835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoki K., Li Y., Zhu T., Wu J., Guan K.-L. TSC2 Is Phosphorylated and Inhibited by Akt and Suppresses MTOR Signalling. Nat. Cell Biol. 2002;4:648–657. doi: 10.1038/ncb839.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb839</ArticleId>
            <ArticleId IdType="pubmed">12172553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery. Cell. 1997;91:231–241. doi: 10.1016/S0092-8674(00)80405-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0092-8674(00)80405-5</ArticleId>
            <ArticleId IdType="pubmed">9346240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akiyama H., Kamiguchi H. Phosphatidylinositol 3-Kinase Facilitates Microtubule-Dependent Membrane Transport for Neuronal Growth Cone Guidance. J. Biol. Chem. 2010;285:41740–41748. doi: 10.1074/jbc.M110.156489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M110.156489</ArticleId>
            <ArticleId IdType="pmc">PMC3009901</ArticleId>
            <ArticleId IdType="pubmed">21041312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grider M.H., Park D., Spencer D.M., Shine H.D. Lipid Raft-Targeted Akt Promotes Axonal Branching and Growth Cone Expansion via MTOR and Rac1, Respectively. J. Neurosci. Res. 2009;87:3033–3042. doi: 10.1002/jnr.22140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jnr.22140</ArticleId>
            <ArticleId IdType="pmc">PMC6561343</ArticleId>
            <ArticleId IdType="pubmed">19530170</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaworski J., Spangler S., Seeburg D.P., Hoogenraad C.C., Sheng M. Control of Dendritic Arborization by the Phosphoinositide-3′-Kinase-Akt-Mammalian Target of Rapamycin Pathway. J. Neurosci. 2005;25:11300–11312. doi: 10.1523/JNEUROSCI.2270-05.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2270-05.2005</ArticleId>
            <ArticleId IdType="pmc">PMC6725892</ArticleId>
            <ArticleId IdType="pubmed">16339025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar V., Zhang M.-X., Swank M.W., Kunz J., Wu G.-Y. Regulation of Dendritic Morphogenesis by Ras-PI3K-Akt-MTOR and Ras-MAPK Signaling Pathways. J. Neurosci. 2005;25:11288–11299. doi: 10.1523/JNEUROSCI.2284-05.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2284-05.2005</ArticleId>
            <ArticleId IdType="pmc">PMC6725910</ArticleId>
            <ArticleId IdType="pubmed">16339024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Markus A., Zhong J., Snider W.D. Raf and Akt Mediate Distinct Aspects of Sensory Axon Growth. Neuron. 2002;35:65–76. doi: 10.1016/S0896-6273(02)00752-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0896-6273(02)00752-3</ArticleId>
            <ArticleId IdType="pubmed">12123609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Read D.E., Gorman A.M. Involvement of Akt in Neurite Outgrowth. Cell. Mol. Life Sci. 2009;66:2975–2984. doi: 10.1007/s00018-009-0057-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-009-0057-8</ArticleId>
            <ArticleId IdType="pubmed">19504044</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng J., Shen W.-H., Lu T.-J., Zhou Y., Chen Q., Wang Z., Xiang T., Zhu Y.-C., Zhang C., Duan S., et al.  Clathrin-Dependent Endocytosis Is Required for TrkB-Dependent Akt-Mediated Neuronal Protection and Dendritic Growth. J. Biol. Chem. 2008;283:13280–13288. doi: 10.1074/jbc.M709930200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M709930200</ArticleId>
            <ArticleId IdType="pubmed">18353779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cuesto G., Enriquez-Barreto L., Carames C., Cantarero M., Gasull X., Sandi C., Ferrus A., Acebes A., Morales M. Phosphoinositide-3-Kinase Activation Controls Synaptogenesis and Spinogenesis in Hippocampal Neurons. J. Neurosci. 2011;31:2721–2733. doi: 10.1523/JNEUROSCI.4477-10.2011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4477-10.2011</ArticleId>
            <ArticleId IdType="pmc">PMC6623769</ArticleId>
            <ArticleId IdType="pubmed">21414895</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bruel-Jungerman E., Veyrac A., Dufour F., Horwood J., Laroche S., Davis S. Inhibition of PI3K-Akt Signaling Blocks Exercise-Mediated Enhancement of Adult Neurogenesis and Synaptic Plasticity in the Dentate Gyrus. PLoS ONE. 2009;4:e7901.  doi: 10.1371/journal.pone.0007901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0007901</ArticleId>
            <ArticleId IdType="pmc">PMC2775944</ArticleId>
            <ArticleId IdType="pubmed">19936256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horwood J.M., Dufour F., Laroche S., Davis S. Signalling Mechanisms Mediated by the Phosphoinositide 3-Kinase/Akt Cascade in Synaptic Plasticity and Memory in the Rat. Eur. J. Neurosci. 2006;23:3375–3384. doi: 10.1111/j.1460-9568.2006.04859.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1460-9568.2006.04859.x</ArticleId>
            <ArticleId IdType="pubmed">16820027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kocsis K., Frank R., Szabó J., Knapp L., Kis Z., Farkas T., Vécsei L., Toldi J. Acetyl-l-Carnitine Restores Synaptic Transmission and Enhances the Inducibility of Stable LTP after Oxygen–Glucose Deprivation. Neuroscience. 2016;332:203–211. doi: 10.1016/j.neuroscience.2016.06.046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2016.06.046</ArticleId>
            <ArticleId IdType="pubmed">27378558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sui L., Wang J., Li B.-M. Role of the Phosphoinositide 3-Kinase-Akt-Mammalian Target of the Rapamycin Signaling Pathway in Long-Term Potentiation and Trace Fear Conditioning Memory in Rat Medial Prefrontal Cortex. Learn. Mem. 2008;15:762–776. doi: 10.1101/lm.1067808.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/lm.1067808</ArticleId>
            <ArticleId IdType="pubmed">18832563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W.-F., Wu L., Du Z.-R., Chen L., Xu A.-L., Chen X.-H., Teng J.-J., Wong M.-S. Neuroprotective Properties of Icariin in MPTP-Induced Mouse Model of Parkinson’s Disease: Involvement of PI3K/Akt and MEK/ERK Signaling Pathways. Phytomedicine. 2017;25:93–99. doi: 10.1016/j.phymed.2016.12.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.phymed.2016.12.017</ArticleId>
            <ArticleId IdType="pubmed">28190476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heras-Sandoval D., Pérez-Rojas J.M., Hernández-Damián J., Pedraza-Chaverri J. The Role of PI3K/AKT/MTOR Pathway in the Modulation of Autophagy and the Clearance of Protein Aggregates in Neurodegeneration. Cell. Signal. 2014;26:2694–2701. doi: 10.1016/j.cellsig.2014.08.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2014.08.019</ArticleId>
            <ArticleId IdType="pubmed">25173700</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Humbert S., Bryson E.A., Cordelières F.P., Connors N.C., Datta S.R., Finkbeiner S., Greenberg M.E., Saudou F. The IGF-1/Akt Pathway Is Neuroprotective in Huntington’s Disease and Involves Huntingtin Phosphorylation by Akt. Dev. Cell. 2002;2:831–837. doi: 10.1016/S1534-5807(02)00188-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1534-5807(02)00188-0</ArticleId>
            <ArticleId IdType="pubmed">12062094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sánchez-Alegría K., Flores-León M., Avila-Muñoz E., Rodríguez-Corona N., Arias C. PI3K Signaling in Neurons: A Central Node for the Control of Multiple Functions. Int. J. Mol. Sci. 2018;19:3725.  doi: 10.3390/ijms19123725.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms19123725</ArticleId>
            <ArticleId IdType="pmc">PMC6321294</ArticleId>
            <ArticleId IdType="pubmed">30477115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheuer T. Regulation of Sodium Channel Activity by Phosphorylation. Semin. Cell Dev. Biol. 2011;22:160–165. doi: 10.1016/j.semcdb.2010.10.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semcdb.2010.10.002</ArticleId>
            <ArticleId IdType="pmc">PMC3423337</ArticleId>
            <ArticleId IdType="pubmed">20950703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang L., Fan L., Tao B., Yaster M., Tao Y.-X. Protein Kinase B/Akt Is Required for Complete Freund’s Adjuvant-Induced Upregulation of Nav1.7 and Nav1.8 in Primary Sensory Neurons. J. Pain. 2013;14:638–647. doi: 10.1016/j.jpain.2013.01.778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpain.2013.01.778</ArticleId>
            <ArticleId IdType="pmc">PMC3672264</ArticleId>
            <ArticleId IdType="pubmed">23642408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arribas-Blázquez M., Piniella D., Olivos-Oré L.A., Bartolomé-Martín D., Leite C., Giménez C., Artalejo A.R., Zafra F. Regulation of the Voltage-Dependent Sodium Channel NaV1.1 by AKT1. Neuropharmacology. 2021;197:108745. doi: 10.1016/j.neuropharm.2021.108745.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuropharm.2021.108745</ArticleId>
            <ArticleId IdType="pubmed">34375627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsu W.-C., Nenov M.N., Shavkunov A., Panova N., Zhan M., Laezza F. Identifying a Kinase Network Regulating FGF14:Nav1.6 Complex Assembly Using Split-Luciferase Complementation. PLoS ONE. 2015;10:e0117246.  doi: 10.1371/journal.pone.0117246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0117246</ArticleId>
            <ArticleId IdType="pmc">PMC4319734</ArticleId>
            <ArticleId IdType="pubmed">25659151</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsu W.-C., Scala F., Nenov M.N., Wildburger N.C., Elferink H., Singh A.K., Chesson C.B., Buzhdygan T., Sohail M., Shavkunov A.S., et al.  CK2 Activity Is Required for the Interaction of FGF14 with Voltage-Gated Sodium Channels and Neuronal Excitability. FASEB J. 2016;30:2171–2186. doi: 10.1096/fj.201500161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.201500161</ArticleId>
            <ArticleId IdType="pmc">PMC4871802</ArticleId>
            <ArticleId IdType="pubmed">26917740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>James T.F., Nenov M.N., Wildburger N.C., Lichti C.F., Luisi J., Vergara F., Panova-Electronova N.I., Nilsson C.L., Rudra J.S., Green T.A., et al.  The Nav1.2 Channel Is Regulated by GSK3. Biochim. Biophys. Acta Gen. Subj. 2015;1850:832–844. doi: 10.1016/j.bbagen.2015.01.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbagen.2015.01.011</ArticleId>
            <ArticleId IdType="pmc">PMC4336163</ArticleId>
            <ArticleId IdType="pubmed">25615535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scala F., Nenov M.N., Crofton E.J., Singh A.K., Folorunso O., Zhang Y., Chesson B.C., Wildburger N.C., James T.F., Alshammari M.A., et al.  Environmental Enrichment and Social Isolation Mediate Neuroplasticity of Medium Spiny Neurons through the GSK3 Pathway. Cell Rep. 2018;23:555–567. doi: 10.1016/j.celrep.2018.03.062.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2018.03.062</ArticleId>
            <ArticleId IdType="pmc">PMC6150488</ArticleId>
            <ArticleId IdType="pubmed">29642012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shavkunov A.S., Wildburger N.C., Nenov M.N., James T.F., Buzhdygan T.P., Panova-Elektronova N.I., Green T.A., Veselenak R.L., Bourne N., Laezza F. The Fibroblast Growth Factor 14·voltage-Gated Sodium Channel Complex Is a New Target of Glycogen Synthase Kinase 3 (GSK3) J. Biol. Chem. 2013;288:19370–19385. doi: 10.1074/jbc.M112.445924.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.445924</ArticleId>
            <ArticleId IdType="pmc">PMC3707642</ArticleId>
            <ArticleId IdType="pubmed">23640885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dvorak N.M., Tapia C.M., Baumgartner T.J., Singh J., Laezza F., Singh A.K. Pharmacological Inhibition of Wee1 Kinase Selectively Modulates the Voltage-Gated Na+ Channel 1.2 Macromolecular Complex. Cells. 2021;10:3103.  doi: 10.3390/cells10113103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells10113103</ArticleId>
            <ArticleId IdType="pmc">PMC8619224</ArticleId>
            <ArticleId IdType="pubmed">34831326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milescu L.S., Bean B.P., Smith J.C. Isolation of Somatic Na+ Currents by Selective Inactivation of Axonal Channels with a Voltage Prepulse. J. Neurosci. 2010;30:7740–7748. doi: 10.1523/JNEUROSCI.6136-09.2010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.6136-09.2010</ArticleId>
            <ArticleId IdType="pmc">PMC2913474</ArticleId>
            <ArticleId IdType="pubmed">20519549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dvorak N.M., Tapia C.M., Singh A.K., Baumgartner T.J., Wang P., Chen H., Wadsworth P.A., Zhou J., Laezza F. Pharmacologically Targeting the Fibroblast Growth Factor 14 Interaction Site on the Voltage-Gated Na+ Channel 1.6 Enables Isoform-Selective Modulation. Int. J. Mol. Sci. 2021;22:13541.  doi: 10.3390/ijms222413541.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms222413541</ArticleId>
            <ArticleId IdType="pmc">PMC8708424</ArticleId>
            <ArticleId IdType="pubmed">34948337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Wart A., Matthews G. Impaired Firing and Cell-Specific Compensation in Neurons Lacking Nav1.6 Sodium Channels. J. Neurosci. 2006;26:7172–7180. doi: 10.1523/JNEUROSCI.1101-06.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1101-06.2006</ArticleId>
            <ArticleId IdType="pmc">PMC6673932</ArticleId>
            <ArticleId IdType="pubmed">16822974</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Royeck M., Horstmann M.-T., Remy S., Reitze M., Yaari Y., Beck H. Role of Axonal Na V 1.6 Sodium Channels in Action Potential Initiation of CA1 Pyramidal Neurons. J. Neurophysiol. 2008;100:2361–2380. doi: 10.1152/jn.90332.2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/jn.90332.2008</ArticleId>
            <ArticleId IdType="pubmed">18650312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nelson A.D., Jenkins P.M. Axonal Membranes and Their Domains: Assembly and Function of the Axon Initial Segment and Node of Ranvier. Front. Cell. Neurosci. 2017;11:136. doi: 10.3389/fncel.2017.00136.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2017.00136</ArticleId>
            <ArticleId IdType="pmc">PMC5422562</ArticleId>
            <ArticleId IdType="pubmed">28536506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zybura A., Hudmon A., Cummins T.R. Distinctive Properties and Powerful Neuromodulation of Nav1.6 Sodium Channels Regulates Neuronal Excitability. Cells. 2021;10:1595.  doi: 10.3390/cells10071595.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells10071595</ArticleId>
            <ArticleId IdType="pmc">PMC8307729</ArticleId>
            <ArticleId IdType="pubmed">34202119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Re J., Hsu W.-C.J., Kayasandik C.B., Fularczyk N., James T.F., Nenov M.N., Negi P., Marosi M., Scala F., Prasad S., et al.  Inhibition of AKT Signaling Alters ΒIV Spectrin Distribution at the AIS and Increases Neuronal Excitability. Front. Mol. Neurosci. 2021;14:128. doi: 10.3389/fnmol.2021.643860.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnmol.2021.643860</ArticleId>
            <ArticleId IdType="pmc">PMC8278006</ArticleId>
            <ArticleId IdType="pubmed">34276302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hedstrom K.L., Ogawa Y., Rasband M.N. AnkyrinG Is Required for Maintenance of the Axon Initial Segment and Neuronal Polarity. J. Cell Biol. 2008;183:635–640. doi: 10.1083/jcb.200806112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200806112</ArticleId>
            <ArticleId IdType="pmc">PMC2582894</ArticleId>
            <ArticleId IdType="pubmed">19001126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jenkins S.M., Bennett V. Ankyrin-G Coordinates Assembly of the Spectrin-Based Membrane Skeleton, Voltage-Gated Sodium Channels, and L1 CAMs at Purkinje Neuron Initial Segments. J. Cell Biol. 2001;155:739–746. doi: 10.1083/jcb.200109026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200109026</ArticleId>
            <ArticleId IdType="pmc">PMC2150881</ArticleId>
            <ArticleId IdType="pubmed">11724816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evans M.D., Dumitrescu A.S., Kruijssen D.L.H., Taylor S.E., Grubb M.S. Rapid Modulation of Axon Initial Segment Length Influences Repetitive Spike Firing. Cell Rep. 2015;13:1233–1245. doi: 10.1016/j.celrep.2015.09.066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2015.09.066</ArticleId>
            <ArticleId IdType="pmc">PMC4646840</ArticleId>
            <ArticleId IdType="pubmed">26526995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuba H., Yamada R., Ishiguro G., Adachi R. Redistribution of Kv1 and Kv7 Enhances Neuronal Excitability during Structural Axon Initial Segment Plasticity. Nat. Commun. 2015;6:8815. doi: 10.1038/ncomms9815.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms9815</ArticleId>
            <ArticleId IdType="pmc">PMC4673506</ArticleId>
            <ArticleId IdType="pubmed">26581625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wadsworth P.A., Singh A.K., Nguyen N., Dvorak N.M., Tapia C.M., Russell W.K., Stephan C., Laezza F. JAK2 Regulates Nav1.6 Channel Function via FGF14Y158 Phosphorylation. Biochim. Biophys. Acta Mol. Cell Res. 2020;1867:118786. doi: 10.1016/j.bbamcr.2020.118786.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbamcr.2020.118786</ArticleId>
            <ArticleId IdType="pmc">PMC7984254</ArticleId>
            <ArticleId IdType="pubmed">32599005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ali S.R., Liu Z., Nenov M.N., Folorunso O., Singh A., Scala F., Chen H., James T.F., Alshammari M., Panova-Elektronova N.I., et al.  Functional Modulation of Voltage-Gated Sodium Channels by a FGF14-Based Peptidomimetic. ACS Chem. Neurosci. 2018;9:976–987. doi: 10.1021/acschemneuro.7b00399.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acschemneuro.7b00399</ArticleId>
            <ArticleId IdType="pmc">PMC6033619</ArticleId>
            <ArticleId IdType="pubmed">29359916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bergeron Y., Bureau G., Laurier-Laurin M.-É., Asselin E., Massicotte G., Cyr M. Genetic Deletion of Akt3 Induces an Endophenotype Reminiscent of Psychiatric Manifestations in Mice. Front. Mol. Neurosci. 2017;10:102. doi: 10.3389/fnmol.2017.00102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnmol.2017.00102</ArticleId>
            <ArticleId IdType="pmc">PMC5385361</ArticleId>
            <ArticleId IdType="pubmed">28442992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gogos J.A. Convergent Evidence for Impaired AKT1-GSK3β Signaling in Schizophrenia. Nat. Genet. 2004;36:131–137. doi: 10.1038/ng1296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng1296</ArticleId>
            <ArticleId IdType="pubmed">14745448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Emamian E.S., Beaulieu J.-M., Bagni C., Salahpour A. AKT/GSK3 Signaling Pathway and Schizophrenia. Front. Mol. Neurosci. 2012;5:33. doi: 10.3389/fnmol.2012.00033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnmol.2012.00033</ArticleId>
            <ArticleId IdType="pmc">PMC3304298</ArticleId>
            <ArticleId IdType="pubmed">22435049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leibrock C., Ackermann T.F., Hierlmeier M., Lang F., Borgwardt S., Lang U.E. Akt2 Deficiency Is Associated with Anxiety and Depressive Behavior in Mice. Cell. Physiol. Biochem. 2013;32:766–777. doi: 10.1159/000354478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000354478</ArticleId>
            <ArticleId IdType="pubmed">24080829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gabbouj S., Ryhänen S., Marttinen M., Wittrahm R., Takalo M., Kemppainen S., Martiskainen H., Tanila H., Haapasalo A., Hiltunen M., et al.  Altered Insulin Signaling in Alzheimer’s Disease Brain—Special Emphasis on PI3K-Akt Pathway. Front. Neurosci. 2019;13:629. doi: 10.3389/fnins.2019.00629.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2019.00629</ArticleId>
            <ArticleId IdType="pmc">PMC6591470</ArticleId>
            <ArticleId IdType="pubmed">31275108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steen E., Terry B.M., Rivera E.J., Cannon J.L., Neely T.R., Tavares R., Xu X.J., Wands J.R., de la Monte S.M. Impaired Insulin and Insulin-like Growth Factor Expression and Signaling Mechanisms in Alzheimer’s Disease—Is This Type 3 Diabetes? J. Alzheimer’s Dis. 2005;7:63–80. doi: 10.3233/JAD-2005-7107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/JAD-2005-7107</ArticleId>
            <ArticleId IdType="pubmed">15750215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hashimoto M., Bar-on P., Ho G., Takenouchi T., Rockenstein E., Crews L., Masliah E. β-Synuclein Regulates Akt Activity in Neuronal Cells. J. Biol. Chem. 2004;279:23622–23629. doi: 10.1074/jbc.M313784200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M313784200</ArticleId>
            <ArticleId IdType="pubmed">15026413</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rai S.N., Dilnashin H., Birla H., Singh S.S., Zahra W., Rathore A.S., Singh B.K., Singh S.P. The Role of PI3K/Akt and ERK in Neurodegenerative Disorders. Neurotox. Res. 2019;35:775–795. doi: 10.1007/s12640-019-0003-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12640-019-0003-y</ArticleId>
            <ArticleId IdType="pubmed">30707354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Timmons S., Coakley M.F., Moloney A.M., O’Neill C. Akt Signal Transduction Dysfunction in Parkinson’s Disease. Neurosci. Lett. 2009;467:30–35. doi: 10.1016/j.neulet.2009.09.055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neulet.2009.09.055</ArticleId>
            <ArticleId IdType="pubmed">19800394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Willard S.S., Koochekpour S. Glutamate, Glutamate Receptors, and Downstream Signaling Pathways. Int. J. Biol. Sci. 2013;9:948–959. doi: 10.7150/ijbs.6426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/ijbs.6426</ArticleId>
            <ArticleId IdType="pmc">PMC3805900</ArticleId>
            <ArticleId IdType="pubmed">24155668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dvorak N.M., Wadsworth P.A., Wang P., Chen H., Zhou J., Laezza F. Bidirectional Modulation of the Voltage-Gated Sodium (Nav1.6) Channel by Rationally Designed Peptidomimetics. Molecules. 2020;25:3365.  doi: 10.3390/molecules25153365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules25153365</ArticleId>
            <ArticleId IdType="pmc">PMC7435778</ArticleId>
            <ArticleId IdType="pubmed">32722255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang P., Wadsworth P.A., Dvorak N.M., Singh A.K., Chen H., Liu Z., Zhou R., Holthauzen L.M.F., Zhou J., Laezza F. Design, Synthesis, and Pharmacological Evaluation of Analogues Derived from the PLEV Tetrapeptide as Protein–Protein Interaction Modulators of Voltage-Gated Sodium Channel 1.6. J. Med. Chem. 2020;63:11522–11547. doi: 10.1021/acs.jmedchem.0c00531.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.jmedchem.0c00531</ArticleId>
            <ArticleId IdType="pmc">PMC8317200</ArticleId>
            <ArticleId IdType="pubmed">33054193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tapia C.M., Folorunso O., Singh A.K., McDonough K., Laezza F. Effects of Deltamethrin Acute Exposure on Nav1.6 Channels and Medium Spiny Neurons of the Nucleus Accumbens. Toxicology. 2020;440:152488. doi: 10.1016/j.tox.2020.152488.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tox.2020.152488</ArticleId>
            <ArticleId IdType="pmc">PMC8082574</ArticleId>
            <ArticleId IdType="pubmed">32387285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alexander R.P.D., Mitry J., Sareen V., Khadra A., Bowie D. Cerebellar Stellate Cell Excitability Is Coordinated by Shifts in the Gating Behavior of Voltage-Gated Na+ and A-Type K+ Channels. eNeuro. 2019;6:ENEURO.0126-19.2019.  doi: 10.1523/ENEURO.0126-19.2019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/ENEURO.0126-19.2019</ArticleId>
            <ArticleId IdType="pmc">PMC6553571</ArticleId>
            <ArticleId IdType="pubmed">31110133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pablo J.L., Wang C., Presby M.M., Pitt G.S. Polarized Localization of Voltage-Gated Na+ Channels Is Regulated by Concerted FGF13 and FGF14 Action. Proc. Natl. Acad. Sci. USA. 2016;113:E2665–E2674. doi: 10.1073/pnas.1521194113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1521194113</ArticleId>
            <ArticleId IdType="pmc">PMC4868475</ArticleId>
            <ArticleId IdType="pubmed">27044086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alshammari M.A., Alshammari T.K., Laezza F. Improved Methods for Fluorescence Microscopy Detection of Macromolecules at the Axon Initial Segment. Front. Cell. Neurosci. 2016;10:5. doi: 10.3389/fncel.2016.00005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2016.00005</ArticleId>
            <ArticleId IdType="pmc">PMC4754416</ArticleId>
            <ArticleId IdType="pubmed">26909021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katz E., Stoler O., Scheller A., Khrapunsky Y., Goebbels S., Kirchhoff F., Gutnick M.J., Wolf F., Fleidervish I.A. Role of Sodium Channel Subtype in Action Potential Generation by Neocortical Pyramidal Neurons. Proc. Natl. Acad. Sci. USA. 2018;115:E7184–E7192. doi: 10.1073/pnas.1720493115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1720493115</ArticleId>
            <ArticleId IdType="pmc">PMC6065046</ArticleId>
            <ArticleId IdType="pubmed">29991598</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
